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found that ghrelin plasma concentrations in young adults 
who had been exposed to cigarette smoke in utero were sig-
nificantly higher than in those without prenatal smoke expo-
sure. Moreover, individuals with intrauterine nicotine expo-
sure showed a significantly higher prevalence of own smok-
ing habits and lower educational status compared to those 
in the group without exposure.  Conclusion: Smoking during 
pregnancy may be considered as an adverse intrauterine in-
fluence that may alter the endocrine-metabolic status of the 
offspring even until early adulthood. 
 © 2014 S. Karger AG, Basel 
 Introduction 
 The gut-derived peptide hormone ghrelin stimulates 
appetite by providing signals to hypothalamic growth 
hormone secretagogue receptors  [1–5] . Plasma ghrelin is 
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 Abstract 
 Background: The appetite-stimulating hormone ghrelin is a 
fundamental regulator of human energy metabolism. A se-
ries of studies support the notion that long-term appetite 
and weight regulation may be already programmed in early 
life and it could be demonstrated that the intrauterine envi-
ronment affects the ghrelin system of the offspring. Animal 
studies have also shown that intrauterine programming of 
orexigenic systems persists even until adolescence/adult-
hood.  Methods: We hypothesized that plasma ghrelin con-
centrations in adulthood may be associated with the intra-
uterine exposure to cigarette smoke. We examined this hy-
pothesis in a sample of 19-year-olds followed up since birth 
in the framework of the Mannheim Study of Children at Risk, 
an ongoing epidemiological cohort study of the long-term 
outcome of early risk factors.  Results: As a main finding, we 
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increased in states of negative energy balance, such as 
starvation, and decreased during states of positive energy 
balance, such as feeding  [6] . Ghrelin has thus been found 
to be inversely related to the body mass index (BMI) in 
patients with eating disorders, e.g. morbidly obese pa-
tients  [7–9] and patients with anorexia and bulimia ner-
vosa  [10–12] .
 A series of studies support the notion that long-term 
appetite and weight regulation may be already pro-
grammed in early life  [13–15] . A high weight gain in in-
fancy has been associated with both body fat and concen-
trations of ghrelin in adolescence  [16] . In addition, it 
could be demonstrated that the intrauterine environment 
affects the ghrelin system of the offspring. A study by 
Smith et al.  [17] revealed that offspring (aged 2.5–25 
years) born before an anti-obesity surgery (biliopancre-
atic diversion bariatric surgery) of their mother had low-
er ghrelin concentrations than their siblings born after 
the mother’s anti-obesity surgery. The profound effect of 
intrauterine growth retardation induced by methyl-do-
nor deficiency  on ghrelin function  [18] suggests the in-
volvement of transgenerationally mediated epigenetic 
mechanisms. In utero exposure to cigarette smoke, a 
known factor causing epigenetic modifications  [19, 20] , 
led to significantly higher serum ghrelin concentrations 
in adult male rats compared to a control group of rats 
born to mothers without cigarette smoke exposure dur-
ing gestation  [21] . In humans, the newborns of smoking 
mothers were found to exhibit significantly higher cord 
blood levels of ghrelin than those of nonsmoking mothers 
 [22] .
 Further animal studies have also shown that intrauter-
ine programming of obesity-related orexigenic systems 
persists even to adolescence/adulthood. Using a rat mod-
el of intrauterine caloric growth restriction, Nagata et al. 
 [23] found that pups of undernourished mothers were 
hyperphagic and heavier, and had higher ghrelin levels 
until the adult age of 7 months compared to rats of moth-
ers that had been fed ad libitum during gestation. Con-
firming these results, Yousheng et al.  [24] provided an 
electrophysiological basis for altered ingestive behavior 
by studying the postmortem brain tissue of adult rats that 
had been previously subjected to maternal food restric-
tion during gestation/lactation.
 Based on the observations described above, we hy-
pothesized that plasma ghrelin concentrations in adult-
hood may be associated with the intrauterine exposure to 
cigarette smoke. Here, we examined this hypothesis in a 
sample of 19-year-olds from a long-term, prospective, ep-
idemiological cohort study followed up since birth.
 Materials and Methods  
 Subjects 
 This investigation was conducted in the framework of the 
Mannheim Study of Children at Risk  [25, 26] , an ongoing epide-
miological cohort study of the long-term outcome of early risk fac-
tors. The initial sample consisted of 384 children of predominant-
ly (>99.0%) European descent born between 1986 and 1988. In-
fants were recruited from two obstetric and six children’s hospitals 
of the Rhine Neckar Region (Germany) and were included con-
secutively into the sample according to a two-factorial design in-
tended to enrich and control the risk status of the sample (factor 1 
varying the degree of obstetric complications and factor 2 the de-
gree of psychosocial adversity  [25, 26] ). As a result, approximately 
one third of the study sample had experienced severe obstetric 
complications, while about one third of the families suffered from 
severe psychosocial adversities, such as a parental psychiatric dis-
order, marital discord or young parenthood. Only firstborn chil-
dren with singleton births and German-speaking parents were en-
rolled in the study. Furthermore, children with severe physical 
handicaps, obvious genetic defects or metabolic diseases were ex-
cluded. Assessments were conducted at the age of 3 months and at 
regular intervals throughout development. The present analysis 
comprises data from 266 young adults (123 males and 143 females) 
who agreed to participate in the follow-up examination at the age 
of 19 years including blood sampling and for whom data on all 
relevant variables were complete. The study was approved by the 
Ethics Committee of the University of Heidelberg and written in-
formed consent was obtained from all participants.
 Assessments  
 The variable  obstetric risk status mirrored an obstetric risk 
score obtained by counting the presence of nine adverse condi-
tions during pregnancy, delivery and the postnatal period  [25] . 
Early  psychosocial risk status was assessed according to an ‘en-
riched’ family adversity index measuring the presence of 11 ad-
verse family factors covering characteristics of the parents, the 
partnership and the family environment during a 1-year period 
prior to birth. The participants’  birth weight and  gestational age 
were extracted from infant neonatal records. The sample also com-
prised infants suffering from obstetric complications: 72 (27.1%) 
participants were born by premature birth (gestational age <37 
weeks) and 36 (13.5%) were small for gestational age (defined as 
birth weight below the 10th percentile for the gestational age). The 
mothers of 38 (14.3%) participants suffered from  preeclampsia .
 Maternal smoking during pregnancy was determined by a stan-
dardized interview conducted with the mother at the 3-month as-
sessment. Mothers were asked whether they did not smoke (a) or 
smoked up to 5 (b), 10 (c), 20 (d), 40 (e) or more than 40 cigarettes/
day (f) during pregnancy. To avoid power problems due to small 
sample sizes, the latter groups (c–f) were pooled, resulting in a 
three-level variable [0 = nonsmoking: 74.4% (n = 198), 1 = smok-
ing 1–5 cigarettes/day: 10.2% (n = 27) and 2 = smoking >5 ciga-
rettes/day: 15.4% (n = 41)].
 Postnatal smoking of the parents was recorded within the 
framework of a standardized parent interview conducted at all as-
sessments until the participants were aged 15 years. Smoking was 
defined as having smoked at least 5 cigarettes/day in any of the as-
sessments (0 = parents did not smoke, 1 = at least one parent 
smoked until the offspring’s age of 15 years).
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 At the age of 19 years, the  anthropometric assessment included 
weight and height. We calculated the BMI dividing the weight (kg) 
by the height (m 2 ). For the assessment of young adults’ cigarette 
use, participants completed a smoking inventory which is part of 
the substance use questionnaire designed by Müller and Abbet 
 [27] in collaboration with the World Health Organization. The 
 current smoking status was determined using a four-level variable 
reflecting both the frequency and the quantity of smoking: 1 = 
never smoked, 2 = experimental use (smoked up to once per 
month), 3 = regular use (at least weekly) and 4 = dependent use 
(>10 cigarettes/day). In addition, participants were asked for their 
highest level of education at the age of 19 years. Derived from this, 
the dichotomous variable  high school graduation was set to value 1 
for participants achieving the diploma from German secondary 
school qualifying for university admission and 0 in the remainder. 
 Laboratory Methods 
 At the age of 19 years, a laboratory stress procedure was con-
ducted, which comprised repeated blood sampling (for more de-
tails see Buchmann et al.  [28] ). Participants reported to the labora-
tory at 13.00 h. Until their arrival, smoking and food intake were 
allowed ad libitum, but all subjects were asked for the time of their 
last meal. During the study procedure, they needed to abstain from 
nicotine and caloric intake throughout the experiment. At 17.15 h, 
blood samples were collected in tubes pretreated with EDTA and 
aprotinin (2,000 KIU per 7 ml blood), immediately stored on ice 
and spun at 4  °  C within 10 min. The plasma was immediately fro-
zen and stored at –80  °  C. Total ghrelin concentrations were deter-
mined using a commercially available radioimmunoassay kit (Me-
diagnost, Reutlingen, Germany). Intra- and interassay coefficients 
of variation were 2.6–5.3 and 4.8–8.2%, respectively. Three par-
ticipants (1 male and 2 females) were considered as outliers due to 
deviation of more than 2.5 standard deviations from the group 
mean and were excluded from the sample. 
 Data Analysis  
 ANOVA and correlation analyses were conducted in order to 
explore the effects of potentially confounding variables on plasma 
ghrelin levels at the age of 19 years. ANCOVA (analysis of covari-
ance) was used to investigate the effect of tobacco exposure during 
pregnancy on plasma ghrelin concentrations at the age of 19 years 
controlling for potentially confounding factors. All analyses were 
conducted using PASW 18.
 Results 
 Total Cohort 
 In the total study cohort,  gender revealed a significant 
effect on young adults’ ghrelin levels, with females show-
ing higher ghrelin concentrations than males [females 
(n = 143): 0.88 ± 0.25 ng/ml vs. males (n = 123): 0.79 ± 
0.21 ng/ml; p = 0.002]. There was also a significant effect 
of the  current smoking status on ghrelin levels, indicat-
ing higher ghrelin concentrations in smokers compared 
to nonsmokers [dependent user (n = 43): 0.94 ± 0.26 ng/
ml; regular user (n = 58): 0.85 ± 0.23 ng/ml; experimen-
tal user (n = 104): 0.82 ± 0.22 ng/ml; never user (n = 61): 
0.80 ± 0.24 ng/ml; F 3, 262 = 3.53, p = 0.015)]. In addition, 
significant differences emerged for the level of educa-
tion ( high school graduation ). Compared to participants 
with high school graduation, those without showed sig-
nificantly elevated ghrelin concentrations [no high 
school graduation (n = 166): 0.87 ± 0.24 ng/ml vs. high 
school graduation (n = 100): 0.79 ± 0.23 ng/ml; p = 
0.012]. 
 Higher plasma ghrelin levels at the age of 19 years were 
negatively related to  BMI (r = –0.158; p = 0.010). Further-
more, ghrelin showed a tendency to increase with the 
 time since the last meal  (r = 0.119; p = 0.052). There was 
no significant association of plasma ghrelin with  birth 
weight (r = –0.084; p = 0.174),  small for gestational age 
(r = –0.006; p = 0.921) or preeclampsia (r = –0.035; p = 
0.575).
 Intrauterine Exposure to Cigarette Smoking 
 In our cohort, we identified 41 (15.4%) subjects who 
had been exposed to the highest level of intrauterine cig-
arette smoke (>5 cigarettes/day), while 198 (74.4%) sub-
jects were assigned to the lowest level of prenatal smoke 
exposure (nonsmoking mothers). The remaining 27 sub-
jects (10.2%) pertained to the moderate exposure group, 
with mothers smoking 1–5 cigarettes/day ( table 1 ). The 
 psychosocial risk status was significantly different in the 
exposed groups compared to the nonexposed group (p < 
0.001) in terms of higher psychosocial adversity associ-
ated with the degree of cigarette exposure during preg-
nancy ( table 1 ). The groups with moderate and high ex-
posure also showed a significantly higher  current smoking 
status  compared to the nonexposed group  (p < 0.001) and 
a lower prevalence of  high school graduation (p < 0.001). 
These groups also differed in their  plasma ghrelin levels: 
young adults exposed to maternal smoking during preg-
nancy showed increased ghrelin levels depending on their 
degree of exposure (high intrauterine exposure: 0.94 ± 
0.27 ng/ml; moderate 0.83 ± 0.24 ng/ml, and no exposure: 
0.82 ± 0.23 ng/ml; p = 0.016;  table 1 ). Comparisons be-
tween these groups with regard to a number of factors 
known to influence ghrelin concentrations are also pre-
sented in  table 1 . Maternal smoking during pregnancy re-
mained a significant predictor of higher ghrelin levels at 
the age of 19 years in ANCOVA even after controlling for 
 current smoking status and  high school graduation , as well 
as  BMI ,  time since the last meal ,  postnatal parental smok-
ing ,  gender , and participants’  psychosocial and  obstetric 
risk status (F 2, 255 = 3.16, p = 0.043). 
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 Discussion 
 In this study, we investigated plasma ghrelin concen-
trations in 19-year-old participants of an epidemiological 
cohort study followed up since birth and tested the hy-
pothesis that ghrelin levels in early adulthood may be as-
sociated with intrauterine exposure to cigarette smoking. 
According to our findings, tobacco exposure during 
pregnancy was associated with higher ghrelin levels at the 
age of 19 years. Moreover, individuals with intrauterine 
nicotine exposure were found to show a significantly 
higher prevalence of own smoking habits and a lower ed-
ucational status compared to those in the nonexposed 
group. 
 Our findings correspond well with evidence indicating 
that early-life circumstances may lead to individual dif-
ferences in cognitive, social and emotional develop-
ment – and even in mental health  [29] . Numerous studies 
have indicated that exposure to adversity already in utero 
is associated with various structural, physiologic and 
metabolic changes reaching into the adulthood  [30] . En-
tringer et al.  [31] examined telomere length in healthy 
young adults and found that persons whose mothers had 
experienced a severe stressor during the index pregnancy 
had significantly shorter telomeres compared to controls 
whose mothers had an uneventful index pregnancy. As 
shown in an increasing number of studies, the prenatal 
and early perinatal environment (e.g. undernutrition and 
consecutive low birth weight, but also nutritional excess 
or preterm birth for example) may contribute to the risk 
to develop metabolic (hyperinsulinemia, diabetes type 2 
or obesity), cardiovascular (hypertension or coronary 
heart disease), respiratory (asthma or chronic obstructive 
airway disease) and psychiatric complications, including 
addictive disorders in adult life  [32–41] . The exact under-
lying pathogenetic mechanisms are not fully explored, 
but epigenetic modifications are likely to be involved in 
creating susceptibility to those diseases in later life  [42–
45] . Importantly, such modifications are preventable and 
even potentially reversible  [39, 46] . 
 Saad and Abbas  [21] studied serum and testicular 
ghrelin levels in adult male offspring exposed to cigarette 
smoking in utero and found not only higher ghrelin levels 
in serum and testicular homogenates of exposed male rats 
compared to controls but also significant decreases in tes-
ticular weight and testosterone levels, as well as serum 
testosterone, LH and FSH levels. Thus, hyperghrelinemia 
following maternal smoking during pregnancy may con-
 Table 1.  Sample characteristics
 Cigarette exposure during pregnancy
non e
(n = 198)
moderate
(n = 27)
high
(n = 41)
p
value
Males, n (%) 94 (47.5) 10 (37.0) 19 (46.3) 0.594*
Birth weight (mean ± SD), g 2,863 ± 797.25 2,841 ± 883.05 2,650 ± 724.37 0.298
Small for gestational age, n (%) 23 (11.6) 4 (14.8) 9 (22.0) 0.208*
Preeclampsia, n (%) 30 (15.2) 3 (11.1) 5 (12.2) 0.783*
Psychosocial risk status (mean ± SD) 1.42 ± 1.68 2.33 ± 2.13 3.85 ± 2.06 <0.001
Obstetric risk status (mean ± SD) 1.10 ± 1.04 0.89 ± 1.01 1.07 ± 1.01 0.621
Postnatal parental smoking, n (%) 103 (52.0) 26 (96.3) 40 (97.6) <0.001
BMI (mean ± SD) 23.41 ± 4.09 23.69 ± 3.78 23.66 ± 4.40 0.902
Current smoking status, n (%) <0.001*
Never used 56 (28.3) 1 (3.7) 4 (9.8)
Experimental use 81 (40.9) 11 (40.7) 12 (29.3)
Regular use 39 (19.7) 6 (22.2) 13 (31.7)
Dependent use 22 (11.1) 9 (33.3) 12 (29.3)
High school graduation, n (%) 90 (45.5) 4 (14.8) 6 (14.6) <0.001*
Time since last meal (mean ± SD), h 5.37 ± 1.10 5.42 ± 1.04 5.81 ± 1.52 0.651
Plasma ghrelin (mean ± SD), ng/ml 0.82 ± 0.23 0.83 ± 0.24 0.94 ± 0.27 0.016
 Moderate = Maternal prenatal smoking ≤5 cigarettes/day; high = maternal prenatal smoking >5 cigarettes/
day;  none = no maternal prenatal smoking. p values: the group with no exposure is compared to the exposed 
groups (moderate and high exposure). *χ2 test.
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tribute to the suppression of male reproductive function 
in rats  [21] . Ghrelin has been repeatedly shown to attenu-
ate the activity of the hypothalamic-pituitary-gonadal 
axis in animals and humans; it suppressed the secretion 
of LH and FSH in male and female rats  [47, 48] , female 
rhesus monkeys  [49] and female sheep  [50] , but also in 
human males and females  [51–54] . Moreover, ghrelin ap-
pears to be related to memory processes and to be in-
volved in the pathophysiology of psychiatric disorders, 
particularly depression  [55] .
 Our results are in accordance with previous studies 
showing higher ghrelin levels in females than males 
among both healthy individuals  [8, 56, 57] and patients 
with psychiatric disorders, e.g. depression  [58] . In addi-
tion, ghrelin has also been found to be inversely related to 
BMI  [7–9] . However, increased ghrelin levels due to a low 
BMI were not consistently reported  [10–12, 59] . 
 As far as the impact of the smoking status per se on 
plasma ghrelin concentrations is concerned, we obtained 
a significant effect of the  current daily smoking status on 
peripheral ghrelin levels. This finding is in contrast to that 
of a study by Pöykkö et al.  [60] , who found no correlation 
between ghrelin and smoking. Likewise, no significant 
differences in baseline plasma ghrelin concentrations be-
tween habitual smokers and nonsmokers were reported 
by Kokkinos et al.  [61] and Schanze et al.  [62] . However, 
while ghrelin was unchanged in smoking mothers com-
pared to nonsmoking mothers, their newborns showed 
71% higher cord blood ghrelin concentrations than the 
offspring of nonsmoking mothers  [22] . According to 
Bouros et al.  [63] , smoking appeared to acutely increase 
plasma ghrelin concentrations, while a suppression fol-
lowing short-term smoking was observed among non-
smokers  [61] . On the other hand, Lee et al.  [64] showed 
ghrelin levels to decrease after cessation of smoking and 
concluded that other mechanisms than the change in 
plasma ghrelin may lead to weight gain after smoking ces-
sation. 
 Numerous studies have shown that active maternal 
smoking during pregnancy is associated with reduced 
birth weight due to direct causal intrauterine effects  [65, 
66] . In fact, each cigarette smoked per day during the 
third trimester was estimated to decrease birth weight of 
the neonate by 27 g  [67] . On the other hand, intrauterine 
exposure to smoking was associated with obesity in chil-
dren up to school age, and specific effects of cigarette 
smoke have been discussed as being causal to such a find-
ing  [68, 69] . In our cohort, birth weight did not differ sig-
nificantly between infants with and without cigarette 
smoke exposure. At the age of 19 years, again, BMI did 
not differ significantly between both groups (exposure vs. 
no exposure). 
 In order to assess the extent of confounding, we con-
trolled for a wide range of variables, including  psychoso-
cial  and  obstetric risk status , as well as current smoking 
status , BMI and  high school graduation . As food intake 
until 1 p.m. was not strictly standardized, we controlled 
for the  time since the last meal . After a meal, ghrelin is 
suppressed for about 2–6 h  [70, 71] . Therefore, we assume 
that in all subjects ghrelin plasma concentrations reached 
the fasting state at the time of blood sampling. For the 
unlikely case that a preceding meal suppressed ghrelin for 
a longer period of time, we controlled for fasting duration 
in our analyses. Even after controlling for all these factors, 
our main result of ghrelin levels depending on the intra-
uterine exposure to cigarette smoking remained signifi-
cant. Thus, our finding supports a strong association be-
tween fetal exposure to cigarette smoking and lasting al-
terations in ghrelin concentrations. However, as several 
other parameters (e.g. genetic factors) were not assessed, 
our finding cannot imply a causal intrauterine effect of 
maternal smoking. 
 The risks of smoking during pregnancy are well estab-
lished for both mother and child and include sudden in-
fant death, fetal growth restriction, low birth weight, pla-
cental abruption, preterm delivery and respiratory dis-
tress, for example  [72] . Yet, smoking prevalence during 
pregnancy still reaches up to 24%  [73] . In our cohort, we 
identified 41 mothers (15%) reporting that they had 
smoked >5 cigarettes/day during pregnancy. Current in-
vestigations suggest that up to 25% of pregnant smokers 
are missed when self-reporting is relied on and routinely 
collected data in prenatal care may thus not be accurate 
 [74, 75] . Nevertheless, the fact remains that smoking is 
one of the most important modifiable adverse risk factors 
in Western countries. 
 Conclusion 
 We found that in young adults who had been exposed 
to cigarette smoking in utero, ghrelin plasma concentra-
tions were significantly higher than in those without pre-
natal smoke exposure. Therefore, smoking during preg-
nancy may be considered as an adverse intrauterine effect 
that may alter the endocrine-metabolic status of the off-
spring even until early adulthood, thus predisposing to 
the development of metabolic disorders.
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